{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:16:09Z","timestamp":1778793369697,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010874","name":"American Society for Bone and Mineral Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GGP20074"],"award-info":[{"award-number":["GGP20074"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006256","name":"Universit\u00e0 degli Studi dell'Aquila","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bone.2022.116567","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T11:46:43Z","timestamp":1663760803000},"page":"116567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Experimental therapies for osteopetrosis"],"prefix":"10.1016","volume":"165","author":[{"given":"Antonio","family":"Maurizi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2022.116567_bb0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2017.02.002","article-title":"Osteopetroses, emphasizing potential approaches to treatment","volume":"102","author":"Teti","year":"2017","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2022.116567_bb0010","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.048940","article-title":"Autosomal recessive osteopetrosis: mechanisms and treatments","volume":"14","author":"Penna","year":"2021","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bone.2022.116567_bb0015","series-title":"Haematopoietic Stem Cell Transplantation in Autosomal Recessive Osteopetrosis","first-page":"265","author":"Teti","year":"2013"},{"issue":"3","key":"10.1016\/j.bone.2022.116567_bb0020","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/bbrc.1999.0252","article-title":"A new member of tumor necrosis factor ligand family, ODF\/OPGL\/TRANCE\/RANKL, regulates osteoclast differentiation and function","volume":"256","author":"Takahashi","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.bone.2022.116567_bb0025","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1182\/bloodadvances.2018025890","article-title":"Stem cell transplantation for osteopetrosis in patients beyond the age of 5 years","volume":"3","author":"Stepensky","year":"2019","journal-title":"Blood Adv."},{"issue":"9","key":"10.1016\/j.bone.2022.116567_bb0030","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1210\/jc.2017-01127","article-title":"Diagnosis and management of osteopetrosis: consensus guidelines from the osteopetrosis working group","volume":"102","author":"Wu","year":"2017","journal-title":"J.Clin.Endocrinol.Metab."},{"issue":"1","key":"10.1016\/j.bone.2022.116567_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-021-01955-6","article-title":"Haploidentical haematopoietic stem cell transplantation for malignant infantile osteopetrosis and intermediate osteopetrosis: a retrospective analysis of a single centre","volume":"16","author":"Zhu","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.bone.2022.116567_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27010","article-title":"Successful hematopoietic stem cell transplantation for osteopetrosis using reduced intensity conditioning","volume":"65","author":"Shadur","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bone.2022.116567_bb0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fendo.2019.00085","article-title":"One disease, many genes: implications for the treatment of osteopetroses","volume":"10","author":"Penna","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"7","key":"10.1016\/j.bone.2022.116567_bb0050","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nbt.3584","article-title":"Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin","volume":"34","author":"Palchaudhuri","year":"2016","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.bone.2022.116567_bb0055","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.bbmt.2018.12.172","article-title":"Toxicity-free hematopoietic stem cell engraftment achieved with anti-CD117 monoclonal antibody conditioning","volume":"25","author":"Agarwal","year":"2019","journal-title":"Biol.Blood Marrow Transplant."},{"issue":"9693","key":"10.1016\/j.bone.2022.116567_bb0060","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0140-6736(09)60945-4","article-title":"Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1\/2 study","volume":"374","author":"Straathof","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2022.116567_bb0065","unstructured":"E. Abadir C. Bryant S. Larsen G.J. Clark Targeting the niche: depleting haemopoietic stem cells with targeted therapy."},{"issue":"1","key":"10.1016\/j.bone.2022.116567_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-08201-x","article-title":"Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation","volume":"10","author":"Czechowicz","year":"2019","journal-title":"Nat. Commun."},{"issue":"Supplement 1","key":"10.1016\/j.bone.2022.116567_bb0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1182\/blood-2020-137762","article-title":"First report of non-genotoxic conditioning with JSP191 (anti-CD117) and hematopoietic stem cell transplantation in a newly diagnosed patient with severe combined immune deficiency","volume":"136","author":"Agarwal","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bone.2022.116567_bb0080","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaci.2020.04.033","article-title":"Efficacy and safety of anti-CD45\u2013saporin as conditioning agent for RAG deficiency","volume":"147","author":"Castiello","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.bone.2022.116567_bb0085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1359\/jbmr.090715","article-title":"Committed osteoclast precursors colonize the bone and improve the phenotype of a mouse model of autosomal recessive osteopetrosis","volume":"25","author":"Cappariello","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"7753","key":"10.1016\/j.bone.2022.116567_bb0090","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41586-019-1105-7","article-title":"Developmental origin, functional maintenance and genetic rescue of osteoclasts","volume":"568","author":"Jacome-Galarza","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bone.2022.116567_bb0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1182\/bloodadvances.2018023176","article-title":"Successful in utero stem cell transplantation in X-linked severe combined immunodeficiency","volume":"3","author":"Magnani","year":"2019","journal-title":"Blood Adv."},{"issue":"41","key":"10.1016\/j.bone.2022.116567_bb0100","doi-asserted-by":"crossref","first-page":"14629","DOI":"10.1073\/pnas.0507637102","article-title":"Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero","volume":"102","author":"Frattini","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.bone.2022.116567_bb0105","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2353\/ajpath.2009.080688","article-title":"Fetal liver cells transplanted in utero rescue the osteopetrotic phenotype in the oc\/oc mouse","volume":"174","author":"Tondelli","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.bone.2022.116567_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28841","article-title":"How we approach malignant infantile osteopetrosis","volume":"68","author":"Even-Or","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"issue":"2","key":"10.1016\/j.bone.2022.116567_bb0115","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood-2015-01-625541","article-title":"Hematopoietic stem cell transplantation for infantile osteopetrosis","volume":"126","author":"Orchard","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bone.2022.116567_bb0120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S8756-3282(99)00278-1","article-title":"The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc\/oc) mutants","volume":"26","author":"Scimeca","year":"2000","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.bone.2022.116567_bb0125","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1182\/blood-2006-12-061382","article-title":"Hematopoietic stem cell\u2013targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc\/oc mice","volume":"109","author":"Johansson","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bone.2022.116567_bb0130","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ymthe.2017.03.018","article-title":"Evolving gene therapy in primary immunodeficiency","volume":"25","author":"Thrasher","year":"2017","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.bone.2022.116567_bb0135","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1089\/hum.2019.047","article-title":"Hematopoietic stem cell-targeted neonatal gene therapy with a clinically applicable lentiviral vector corrects osteopetrosis in oc\/oc mice","volume":"30","author":"L\u00f6fvall","year":"2019","journal-title":"Hum. Gene Ther."},{"issue":"8","key":"10.1016\/j.bone.2022.116567_bb0140","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1089\/hum.2017.053","article-title":"Targeting NSG mice engrafting cells with a clinically applicable lentiviral vector corrects osteoclasts in infantile malignant osteopetrosis","volume":"29","author":"Moscatelli","year":"2018","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.bone.2022.116567_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2013.07.026","article-title":"Lentiviral gene transfer of TCIRG1 into peripheral blood CD34(+) cells restores osteoclast function in infantile malignant osteopetrosis","volume":"57","author":"Moscatelli","year":"2013","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2022.116567_bb0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3324\/haematol.2019.238261","article-title":"Expanded circulating hematopoietic stem\/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis","volume":"106","author":"Capo","year":"2020","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.bone.2022.116567_bb0155","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1016\/S2352-3026(19)30202-9","article-title":"Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1\u20132 safety and feasibility study","volume":"7","author":"Cohen","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.bone.2022.116567_bb0160","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/7651_2014_171","article-title":"Using human induced pluripotent stem cells to model skeletal diseases","volume":"1353","author":"Barruet","year":"2016","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.bone.2022.116567_bb0165","doi-asserted-by":"crossref","first-page":"26761","DOI":"10.1038\/srep26761","article-title":"Human iPSC-derived osteoblasts and osteoclasts together promote bone regeneration in 3D biomaterials","volume":"6","author":"Jeon","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bone.2022.116567_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-017-0754-4","article-title":"Targeted reversion of induced pluripotent stem cells from patients with human cleidocranial dysplasia improves bone regeneration in a rat calvarial bone defect model","volume":"9","author":"Saito","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bone.2022.116567_bb0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mcp.2018.01.001","article-title":"Modeling rare diseases with induced pluripotent stem cell technology","volume":"40","author":"Anderson","year":"2018","journal-title":"Mol. Cell. Probes"},{"issue":"4","key":"10.1016\/j.bone.2022.116567_bb0180","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3390\/jcm3041490","article-title":"The use of patient-specific induced pluripotent stem cells (iPSCs) to identify osteoclast defects in rare genetic bone disorders","volume":"3","author":"Chen","year":"2014","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.bone.2022.116567_bb0185","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.stemcr.2015.08.005","article-title":"Targeted gene correction in osteopetrotic-induced pluripotent stem cells for the generation of functional osteoclasts","volume":"5","author":"Neri","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bone.2022.116567_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2018.101367","article-title":"Generation of a human induced pluripotent stem cell line (BIHi002-A) from a patient with CLCN7-related infantile malignant autosomal recessive osteopetrosis","volume":"35","author":"Hennig","year":"2019","journal-title":"Stem Cell Res."},{"issue":"21","key":"10.1016\/j.bone.2022.116567_bb0195","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2106\/JBJS.19.00558","article-title":"TCIRG1 transgenic rescue of osteoclast function using induced pluripotent stem cells derived from patients with infantile malignant autosomal recessive osteopetrosis","volume":"101","author":"Chen","year":"2019","journal-title":"J. Bone Joint Surg. Am."},{"issue":"1","key":"10.1016\/j.bone.2022.116567_bb0200","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-020-01701-y","article-title":"Generation of gene-corrected functional osteoclasts from osteopetrotic induced pluripotent stem cells","volume":"11","author":"Xian","year":"2020","journal-title":"Stem Cell Res. Ther."},{"issue":"9","key":"10.1016\/j.bone.2022.116567_bb0205","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2013.137","article-title":"Osteopetrosis: genetics, treatment and new insights into osteoclast function","volume":"9","author":"Sobacchi","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.bone.2022.116567_bb0210","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.coi.2006.07.004","article-title":"Mesenchymal stem cells: properties and role in clinical bone marrow transplantation","volume":"18","author":"Le Blanc","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bone.2022.116567_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/412768","article-title":"RANKL cytokine: from pioneer of the osteoimmunology era to cure for a rare disease","volume":"2013","author":"Lo Iacono","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.bone.2022.116567_bb0220","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.biomaterials.2014.12.033","article-title":"Biotechnological approach for systemic delivery of membrane receptor activator of NF-\u03baB ligand (RANKL) active domain into the circulation","volume":"46","author":"Cappariello","year":"2015","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.bone.2022.116567_bb0225","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/sctm.18-0085","article-title":"Mesenchymal stromal cell-seeded biomimetic scaffolds as a factory of soluble RANKL in rankl-deficient osteopetrosis","volume":"8","author":"Menale","year":"2019","journal-title":"Stem Cells Transl. Med."},{"issue":"9","key":"10.1016\/j.bone.2022.116567_bb0230","article-title":"Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2","volume":"4","author":"Capulli","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bone.2022.116567_bb0235","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bone.2013.10.021","article-title":"Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models","volume":"59","author":"Alam","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.bone.2022.116567_bb0240","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bone.2018.02.031","article-title":"RNA interference therapy for autosomal dominant osteopetrosis type 2.Towards the preclinical development","volume":"110","author":"Maurizi","year":"2018","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2022.116567_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/s41413-019-0055-x","article-title":"Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications","volume":"7","author":"Maurizi","year":"2019","journal-title":"Bone Res."},{"key":"10.1016\/j.bone.2022.116567_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115828","article-title":"Transcriptomic and bioinformatic analysis of Clcn7-dependent autosomal dominant osteopetrosis type 2.Preclinical and clinical implications","volume":"144","author":"Norwood","year":"2021","journal-title":"Bone"},{"issue":"24","key":"10.1016\/j.bone.2022.116567_bb0255","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM199506153322402","article-title":"Long-term treatment of osteopetrosis with recombinant human interferon gamma","volume":"332","author":"Key","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bone.2022.116567_bb0260","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM198402163100701","article-title":"Treatment of congenital osteopetrosis with high-dose calcitriol","volume":"310","author":"Key","year":"1984","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bone.2022.116567_bb0265","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/jbmr.2545","article-title":"Interferon gamma, but not calcitriol improves the osteopetrotic phenotypes in ADO2 mice","volume":"30","author":"Alam","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.bone.2022.116567_bb0270","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/jbmr.3715","article-title":"Interferon gamma-1b does not increase markers of bone resorption in autosomal dominant osteopetrosis","volume":"34","author":"Imel","year":"2019","journal-title":"J. Bone Miner. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328222002447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328222002447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:44:14Z","timestamp":1762659854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328222002447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":54,"alternative-id":["S8756328222002447"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2022.116567","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental therapies for osteopetrosis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2022.116567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116567"}}